TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
nDatalyze Corp ( (TSE:NDAT) ) just unveiled an announcement.
nDatalyze Corp. has launched Sigmund v.4, an advanced mental assessment tool designed to cater to the Concierge Health vertical. This release aims to enhance mental and physical performance optimization for high-performance individuals and offers potential applications in medical assessment and executive performance prediction.
Spark’s Take on TSE:NDAT Stock
According to Spark, TipRanks’ AI Analyst, TSE:NDAT is a Underperform.
nDatalyze Corp’s overall stock score reflects significant financial struggles with declining revenues and negative cash flows. Technical indicators suggest a bearish trend, while valuation metrics are unattractive due to persistent losses. Although the company has a strong equity position, operational challenges and reliance on external financing remain concerns. The recent corporate events hold potential but are not enough to offset the current financial and market challenges.
To see Spark’s full report on TSE:NDAT stock, click here.
More about nDatalyze Corp
nDatalyze Corp. operates in the mental health industry, focusing on advanced mental assessment tools. Its primary product, Sigmund, is a machine-learning and AI-enhanced mental predisposition assessment tool, targeting affluent, health-conscious individuals in various high-performance fields.
Average Trading Volume: 44,775
Technical Sentiment Signal: Sell
Current Market Cap: C$826.5K
For a thorough assessment of NDAT stock, go to TipRanks’ Stock Analysis page.